David H. Mack
2023
In 2023, David H. Mack earned a total compensation of $2.2M as President, Chief Executive Officer and Director at PMV Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $295,000 |
|---|---|
| Option Awards | $1,328,712 |
| Salary | $586,083 |
| Total | $2,209,795 |
Mack received $1.3M in option awards, accounting for 60% of the total pay in 2023.
Mack also received $295K in non-equity incentive plan and $586.1K in salary.
Rankings
In 2023, David H. Mack's compensation ranked 462nd out of 2,918 executives tracked by ExecPay. In other words, Mack earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 462 out of 2,918 | 84th |
Division Manufacturing | 267 out of 1,608 | 83rd |
Major group Chemicals And Allied Products | 183 out of 901 | 80th |
Industry group Drugs | 180 out of 864 | 79th |
Industry Pharmaceutical Preparations | 113 out of 622 | 82nd |
Source: SEC filing on April 24, 2024.
Mack's colleagues
We found two more compensation records of executives who worked with David H. Mack at PMV Pharmaceuticals in 2023.